XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,498,666 | $42,477,000 | 1.70% |
| Redmile Group, LLC | 2,412,641 | $41,015,000 | 1.65% |
| SABBY MANAGEMENT, LLC | 202,916 | $3,450,000 | 0.76% |
| ArrowMark Colorado Holdings LLC | 652,748 | $11,097,000 | 0.12% |
| Granahan Investment Management | 82,504 | $1,403,000 | 0.10% |
| OppenheimerFunds, Inc. | 1,000,000 | $17,000,000 | 0.02% |
| FEDERATED HERMES, INC. | 300,000 | $5,100,000 | 0.01% |
| FMR LLC | 2,280,968 | $38,776,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,016 | $17,000 | 0.00% |
| BlackRock Inc. | 645,035 | $10,966,000 | 0.00% |